The global slide stainer market size was estimated at USD 4.37 billion in 2023 and is projected to grow at a CAGR of 6.5% from 2024 to 2030. The market growth is attributed to the growing technological advancements in staining techniques, the increasing prevalence of chronic diseases requiring histological analysis, the growing demand for laboratory automation to improve efficiency and accuracy, and rising investments in healthcare infrastructure globally. According to the World Health Organization (WHO), the global burden of non-communicable diseases, such as cancer, cardiovascular diseases (CVDs), and diabetes, is on the rise, with these conditions accounting for over 70% of all deaths worldwide.
Advancements in staining technologies are also fuelling the market growth. Manufacturers continuously develop innovative staining techniques and reagents that offer improved staining quality, faster processing times, and enhanced compatibility with digital pathology workflows. For instance, in May 2022, Leica Biosystems launched its BOND-PRIME system, which features advanced staining algorithms and a user-friendly interface to streamline the process and improve diagnostic accuracy.
The growing demand for laboratory automation is driving the market growth. Automation streamlines laboratory workflows and reduces turnaround times for test results, improving patient care outcomes. For instance, in November 2023, an article published under the title Cutting-edge Offering and Automation in the Pathology Laboratory stated that adopting automated slide stainers in pathology laboratories has been shown to reduce turnaround times by up to 50% and improve the consistency of staining results.
In addition, the accuracy and consistency of test results and the reduction of laboratory workload have been achieved with automatic and digital slide-staining equipment, which has completely changed how laboratories work. The rapid digitization of imaging methods has led to a greater economy and efficiency in laboratory setups. Glasses can be scanned and digitized with digital slide scanners, allowing medical professionals to collaborate and view data remotely. Laboratory setups are more productive and efficient, and diagnoses are made faster and more accurately. Another technological advancement is the development of new staining methods, such as multiple staining, which allows multiple antigens to be stained on a single slide.
However, rapid technological advancements and innovations are some of the major challenges faced by the market. To remain competitive, manufacturers constantly focus on updating and improving their products as technology advances. This requires large investments in research and development and creates a significant financial burden. Moreover, stainers are subject to strict health regulations, further restraining the market's growth.
This product will be delivered within 1-3 business days.
Advancements in staining technologies are also fuelling the market growth. Manufacturers continuously develop innovative staining techniques and reagents that offer improved staining quality, faster processing times, and enhanced compatibility with digital pathology workflows. For instance, in May 2022, Leica Biosystems launched its BOND-PRIME system, which features advanced staining algorithms and a user-friendly interface to streamline the process and improve diagnostic accuracy.
The growing demand for laboratory automation is driving the market growth. Automation streamlines laboratory workflows and reduces turnaround times for test results, improving patient care outcomes. For instance, in November 2023, an article published under the title Cutting-edge Offering and Automation in the Pathology Laboratory stated that adopting automated slide stainers in pathology laboratories has been shown to reduce turnaround times by up to 50% and improve the consistency of staining results.
In addition, the accuracy and consistency of test results and the reduction of laboratory workload have been achieved with automatic and digital slide-staining equipment, which has completely changed how laboratories work. The rapid digitization of imaging methods has led to a greater economy and efficiency in laboratory setups. Glasses can be scanned and digitized with digital slide scanners, allowing medical professionals to collaborate and view data remotely. Laboratory setups are more productive and efficient, and diagnoses are made faster and more accurately. Another technological advancement is the development of new staining methods, such as multiple staining, which allows multiple antigens to be stained on a single slide.
However, rapid technological advancements and innovations are some of the major challenges faced by the market. To remain competitive, manufacturers constantly focus on updating and improving their products as technology advances. This requires large investments in research and development and creates a significant financial burden. Moreover, stainers are subject to strict health regulations, further restraining the market's growth.
Global Slide Stainer Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global slide stainer market report based on product, technology, application, end-use, and region;- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagents & Kits
- Stains
- Diluents & Buffers
- Blocking Sera & Reagents
- Mounting Media, Fixative Reagents, and Embedded Media
- Probes
- Antibodies
- Equipment
- Automated and Semi-automated Slide Stainer
- Manual Staining Set
- Consumables & Accessories
- Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Hematoxylin and Eosin
- Immunohistochemistry
- Cytology
- Microbiology
- Special Stains
- In-situ Hybridization
- Hematology
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Disease Diagnostics
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-small Lung Cancer
- Other Application
- Medical Research
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Diagnostics Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Other End-users
- Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Slide Stainer Market Variables, Trends & Scope
Chapter 4. Slide Stainer Market: Product Estimates & Trend Analysis
Chapter 5. Slide Stainer Market: Technology Estimates & Trend Analysis
Chapter 6. Slide Stainer Market: Application Estimates & Trend Analysis
Chapter 7. Slide Stainer Market: End Use Estimates & Trend Analysis
Chapter 8. Slide Stainer Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- F Hoffmann-La Roche Ltd
- Danaher Corporation
- Merck KGaA
- Agilent Technologies, Inc.
- BD (Becton, Dickinson, and Company)
- Abcam Limited
- Siemens Healthineers AG
- General Data Company, Inc.
- Biocare Medical, LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4.37 Billion |
| Forecasted Market Value ( USD | $ 6.74 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
